Space-time COVID-19 monitoring in Morocco.
COVID-19
Morocco
control measures
distribution
space-time
Journal
The Pan African medical journal
ISSN: 1937-8688
Titre abrégé: Pan Afr Med J
Pays: Uganda
ID NLM: 101517926
Informations de publication
Date de publication:
2020
2020
Historique:
received:
13
05
2020
accepted:
15
05
2020
entrez:
24
2
2021
pubmed:
25
2
2021
medline:
2
3
2021
Statut:
epublish
Résumé
In Morocco, the first case was detected on March 02, 2020. Few days later, new cases are notified, followed by deaths. The government decided to adopt large-scale drastic measures against the epidemic. This study aims to describe and analyse the COVID-19 distribution in Morocco, according to key measures taken to curb this health problem. An observational study of all cases daily reported by the Ministry of Health of Morocco from 02 March to 05 May 2020, was carried out. A mapping was performed. Before the implementation of the state of health emergency, 86 confirmed cases out of 471 biological examinations carried out have been reported and the highest cumulative incidence (0.43 cases per 100,000 inhabitants) was recorded in Fes-Meknes region. During the 1st quarantine, 2,960 positive cases out of 15,915 examinations carried out have been detected. Marrakech-Safi region was the most affected (15.33 cases per 100,000 inhabitants). Halfway through extended quarantine, 2,173 confirmed cases out of 49,570 biological examinations realized have been notified, the highest cumulative incidence has observed in Draa-Tafilalet region (27.45 cases per 100,000 inhabitants). The highest mortality was observed in Marrakech-Safi region (1.05 deaths per 100,000 inhabitants) and the highest case fatality rate (13.46%) was registered in Souss-Massa region. The strategy adopted by Morocco has enabled it to avoid a health catastrophe. But, it's not over yet. Morocco should continue the massive efforts and reinforce the existing measures against the virus, especially in regions very affected by the epidemic.
Identifiants
pubmed: 33623566
doi: 10.11604/pamj.supp.2020.35.2.23505
pii: PAMJ-SUPP-35-2-41
pmc: PMC7875748
doi:
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
41Informations de copyright
© Fatine Hadrya et al.
Déclaration de conflit d'intérêts
The author declares no competing interests.
Références
Lancet. 2020 Feb 15;395(10223):514-523
pubmed: 31986261
Lancet Public Health. 2020 Apr;5(4):e188-e189
pubmed: 32197116
J Am Geriatr Soc. 2020 May;68(5):926-929
pubmed: 32255507
JAMA. 2020 Apr 28;323(16):1612-1614
pubmed: 32191259
Infect Control Hosp Epidemiol. 2020 Aug;41(8):988-989
pubmed: 32281538
Infect Control Hosp Epidemiol. 2020 Sep;41(9):1119-1120
pubmed: 32307029
Infect Control Hosp Epidemiol. 2020 Jul;41(7):873-874
pubmed: 32241308
BMJ. 2020 Mar 26;368:m1091
pubmed: 32217556
Infect Control Hosp Epidemiol. 2020 Sep;41(9):1114-1115
pubmed: 32295657
Infect Control Hosp Epidemiol. 2020 Jun;41(6):754-755
pubmed: 32192541
Can J Cardiol. 2020 Jun;36(6):915-930
pubmed: 32439306
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
Lancet. 2016 Sep 10;388(10049):1089-1102
pubmed: 27427453
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
Pan Afr Med J. 2018 Oct 25;31:142
pubmed: 31037202
Epidemiol Serv Saude. 2020;29(2):e2020044
pubmed: 32348405
Pulmonology. 2020 Mar - Apr;26(2):114-115
pubmed: 32151613
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Epidemiol Rev. 2018 Jun 1;40(1):4-11
pubmed: 29860342
Viruses. 2020 Mar 27;12(4):
pubmed: 32230900
Epidemiol Serv Saude. 2020 Mar 23;29(1):e2020002
pubmed: 32215535
J Epidemiol. 2020 May 5;30(5):236
pubmed: 32281555
Microbes Infect. 2020 Mar;22(2):69-71
pubmed: 32032682
Nepal J Epidemiol. 2020 Mar 30;10(1):817-820
pubmed: 32257511
Infect Control Hosp Epidemiol. 2020 Sep;41(9):1121
pubmed: 32308188
Eur J Epidemiol. 2020 Apr;35(4):341-345
pubmed: 32306149
Int J Antimicrob Agents. 2020 Jul;56(1):105949
pubmed: 32205204
Lancet Oncol. 2020 May;21(5):e237
pubmed: 32251622